Protecting Generations of Innovations

arrow

An internationally known and trusted name in IP Law

Maier & Maier was established with the goal of providing intellectual property analysis and advice for large, multi-national corporations, universities, middle-market and emerging market companies, and startups and spinouts. We are proud of our ability to advise our clients, and to obtain patent protection for a wide scale of technologies, and offer years of experience in litigation, licensing, and other intellectual property-related issues.

The History of Our Firm

USPTO Announces COVID-19 CARES Act Response And Deadline Extensions

The United States Patent & Trademark Office (“USPTO”) has announced its relief response and deadlines extensions relating to the current COVID-19 “coronavirus” as authorized by the Coronavirus Aid, Relief, and Economic Security Act (CARES Act) executed March 27. In the release, USPTO Director Andrei Iancu explained the steps being taken by the USPTO: “Inventors and […]

Read More »

Arthrex: Federal Circuit Rejects En Banc Rehearing On PTAB Judge Constitutionality

The Federal Circuit has denied the request for rehearing on their Arthrex decision from this past fall. As Maier and Maier’s own Steven Kunin describes here, this rejection sets up a probable grant of certiorari on the issue from the Supreme Court. “The split among the judges provides a roadmap for a probable Supreme Court […]

Read More »

New Rules For Proving Unintentional Delay At USPTO

On March 2, 2020, the USPTO published a new notice in the Federal Register clarifying their practice regarding unintentional delay. “The United States Patent and Trademark Office (USPTO) is clarifying its practice as to situations that will require additional information about whether a delay in seeking the revival of an abandoned application, acceptance of a […]

Read More »